Oisín Biotechnologies

Developer of genetically targeted intervention therapy for age-related diseases. Its technology is based on removing the cells that have entered a non-dividing condition and turns into senescent (zombie) cells. These cells secrete molecules that cause inflammation leading to a large number of age-related diseases.